Last10K.com

Adhera Therapeutics, Inc. (ATRX) SEC Filing 8-K Material Event for the period ending Tuesday, October 23, 2018

Adhera Therapeutics, Inc.

HISTORY TOOLS
CIK: 737207 Ticker: ATRX

View differences made from one to another to evaluate Adhera Therapeutics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Adhera Therapeutics, Inc..

Continue

Assess how Adhera Therapeutics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Adhera Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ATRX
CIK: 737207
Form Type: 8-K Corporate News
Accession Number: 0001493152-18-014855
Submitted to the SEC: Thu Oct 25 2018 4:30:15 PM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Tuesday, October 23, 2018
Industry: Pharmaceutical Preparations
Events:
  1. Vote of Security Holders

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/atrx/0001493152-18-014855.htm